Mesenchymal stromal cell-dependent reprogramming of Kupffer cells is mediated by TNF-α and PGE2 and is crucial for liver transplant tolerance

Abstract

The role of mesenchymal stromal cells (MSCs) in the modulation of liver transplant tolerance has attracted significant interest. However, the interaction between MSCs and Kupffer cells (KCs) has received little attention, and the effect of this interaction on liver transplant tolerance remains unclear. KCs were cultured in the presence and absence of MSCs. After 24 h, cells were treated with lipopolysaccharide (LPS), after which the production of cytokines and the expression of surface antigens were measured for cell function identification. Moreover, the effects of the KCs and the prostaglandin E2 (PGE2) levels produced by the MSCs were determined using an experimental rat liver transplantation model. Blood and liver samples were collected at three time points after transplantation for further analysis. After LPS treatment, when compared with the KC single cultures, the expression of pro-inflammatory cytokines (IL-1β, IL-6, MHC-II, CD40, CD80, and CD86) in the coculture system was down-regulated, whereas the expression of anti-inflammatory cytokines (TGF-β, IL-4, PGE2, and IL-10) was markedly increased. These data indicate that MSCs can reprogram the phenotype of KCs. However, KCs treated with miR/TNF-α (tumor necrosis factor) plasmid prior to coculture to inhibit the production of TNF-α resulted in an inhibition of the reprogramming effect of MSCs. Moreover, overexpression of PGE2 in MSCs increased the effect of MSCs on KC reprogramming. After rat liver transplantation, allograft recipients that received MSCs showed better allograft tolerance when compared with rats in which KC function was inhibited. Furthermore, rats treated with MSCs overexpressing PGE2 demonstrated the best liver tolerance of all of the groups tested. MSCs reprogram the phenotype of KCs through TNF-α and PGE2, and this process is crucial for the immunomodulatory function of MSCs in liver transplantation.

MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma

“…To identify HSCs, expression of α-SMA (a marker of activated HSCs) was confirmed through immunofluorescence and IHC assays of N-HSCs cultured for seven days (Figure 1A and 1B ). After seven days in culture, primary HSCs are known to be activated and to differ from quiescent HSCs (after two days in culture) in biological function [ 20 , 21 ]. HSCs can be immunosuppressive capacity owing to their ability to induce apoptosis in T cells [ 5 ].…”

Down-Regulated Receptor Interacting Protein 140 Is Involved in Lipopolysaccharide-Preconditioning-Induced Inactivation of Kupffer Cells and Attenuation of Hepatic Ischemia Reperfusion Injury

“…The viability of the isolated cells was determined by 0.1% trypan blue (Sigma, USA) exclusion and routinely exceeded 90%. To identify the KCs, immunofluorescence (ED-1 and ED-2) and phagocytic (latex beads and Dil-LDL) assays were used [ 25 , 26 ]. Adenovirus expressing RIP140 (Ad-RIP140) and lentivirus with RIP140-specific siRNA (Jikai Gene Company, China) were used for transfection, manipulated according to the manufacturer’s instructions.…”

Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation

“…The enhancement of PGE2 secretion can effect a variety of other factors besides TNF-α. Indeed, cytokines like PGE2, IDO, IL-4, IL-10, and TGF-ß are immunoregulatory and their expression can be simultaneously upregulated during inflammation through interactive signal pathways 61 . It is known that PGE2 can upregulate IDO1 expression in circulating DCs and induce immune tolerance 62 .…”